Screener
STERIS STE Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: STERIS’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054830
| Line item | June 30,2026 | March 31,2026 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $344.1 | $338.8 |
| Accrued income taxes | 86.5 | 28.6 |
| Accrued payroll and other related liabilities | 153.1 | 221.1 |
| Short-term lease obligations | 35.6 | 35.8 |
| Short-term indebtedness | 243.4 | 118.9 |
| Accrued expenses and other | 420.5 | 401.9 |
| Total current liabilities | 1,283.3 | 1,145.0 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is STERIS's accrued manufacturing costs?
- STERIS (STE) reported accrued manufacturing costs of $153.1M in Q2 2026.
- How has STERIS's accrued manufacturing costs changed year-over-year?
- STERIS's accrued manufacturing costs decreased by 1.0% year-over-year, from $154.7M to $153.1M.
- What is the long-term trend for STERIS's accrued manufacturing costs?
- Over 5 years (2021 to 2026), STERIS's accrued manufacturing costs has grown at a 8.1% compound annual growth rate (CAGR), from $150.08M to $221.1M.
- What does accrued manufacturing costs mean?
- Accrued liabilities related to manufacturing and production activities.
Ask your AI about STERIS's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude